REGENXBIO(RGNX) - 2023 Q2 - Earnings Call Transcript

REGENXBIO Inc. (NASDAQ:RGNX) Q2 2023 Earnings Conference Call August 2, 2023 4:30 PM ET Company Participants Patrick Christmas - Chief Legal Officer Ken Mills - Chief Executive Officer Steve Pakola - Chief Medical Officer Vit Vasista - Chief Financial Officer Conference Call Participants Dane Leone - RJF Alec Stranahan - Bank of America Ellie Merle - UBS Lisa Walter - RBC Andreas Argyrides - Wedbush Securities Caroline Palomeque - Berenberg Capital Markets Operator Good day, and thank you for standing by. W ...